Precision biosciences stock.

Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Precision BioSciences, Inc. Stock price BOERSE MUENCHEN Equities PBS US74019P1084 Biotechnology & Medical Research Real-time BOERSE MUENCHEN. Other stock markets. 09:13:47 2023-11-21 am EST 5-day change 1st Jan Change ...Jun 22, 2022 · Additionally, Precision announced a common stock offering yesterday. The company will “sell 35,971,224 shares of its common stock at a price of $1.39 per share.” Track Precision Biosciences Inc (DTIL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsPrecision BioSciences, Inc is a clinical-stage gene editing company. It is developing ex vivo allogeneic chimeric antigen receptor (CAR) T immunotherapies and ...

Precision BioSciences, Inc. Common Stock (DTIL) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that, on November 21, 2023, the Compensation Committee …Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially ...

Nov 30, 2023 · The stock of Precision Biosciences Inc (NASDAQ: DTIL) has decreased by -9.31 when compared to last closing price of 0.41.Despite this, the company has seen a loss of -11.84% in its stock price over the last five trading days. Business Wire reported 2023-10-23 that DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL) an advanced gene editing […] H.C. Wainwright analyst Patrick Trucchio maintained a Buy rating on Precision BioSciences ( DTIL – Research Report) today and set a price target of $17.00. The company’s shares opened today at ...

In June 2022, Precision announced the closing of an underwritten offering of 35,971,224 shares of its common stock at an offering price of $1.39 per share, ... Precision Biosciences, Inc. Condensed Consolidated Statements of Operations (In thousands, except share and per share amounts)Precision BioSciences, Inc. (DTIL) Stock Price | Stock Quote Nasdaq - MarketScreener PRECISION BIOSCIENCES, INC. Precision BioSciences, Inc. Stock …DURHAM, N.C.--(BUSINESS WIRE)--Jun. 27, 2022-- Precision BioSciences, Inc. (Nasdaq: DTIL) (the “Company”), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced the closing of an underwritten offering of 35,971,224 shares of its common stock at an offering price of $1.39 per share, for total gross proceeds ...Precision Biosciences Stock Earnings. The value each DTIL share was expected to gain vs. the value that each DTIL share actually gained. Precision Biosciences ( DTIL) reported Q3 2023 earnings per share (EPS) of -$0.14, beating estimates of -$0.18 by 21.37%. In the same quarter last year, Precision Biosciences 's earnings per share (EPS) was ...Precision BioSciences Inc Registered Shs's market capitalization is $46.27 M by 120.90 M shares outstanding. Precision BioSciences Stock Snapshot 3.34

Precision BioSciences has a consensus target price of $3.00, suggesting a potential upside of 710.81%. Given Precision BioSciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe Checkpoint Therapeutics is more favorable than Precision BioSciences.

Precision BioSciences market cap as of November 07, 2023 is $0.05B . Precision BioSciences market cap history and chart from 2018 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares ...

Mullen Automotive, Inc. Common Stock. $0.2205 +0.0496 29.02%. Precision BioSciences, Inc. Common Stock (DTIL) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US ... Precision BioSciences Inc Registered Shs's market capitalization is $46.27 M by 120.90 M shares outstanding. Precision BioSciences Stock Snapshot 3.34Currently, the analyst consensus on Precision BioSciences is a Moderate Buy with an average price target of $10.50. See the top stocks recommended by analysts >> DTIL market cap is currently $101 ...Get the latest information on Precision BioSciences Inc (DTIL), a biotechnology company that develops and commercializes genomic tests for cancer and other diseases. …The Investor Relations website contains information about Precision BioSciences's business for stockholders, potential investors, and financial analysts.

Precision BioSciences, which has offices at the historic Venable Center in downtown Durham, filed plans on March 1 with the Securities and Exchange Commission for an initial public offering on the Nasdaq stock exchange. The company would trade under the ticker symbol “DTIL,” according to the filing. The company, which has around 130 ...DURHAM, N.C.--(BUSINESS WIRE)--Jun. 8, 2022-- Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced its latest program updates across its allogeneic CAR T pipeline. The Company provided new clinical data and outlined ...Precision BioSciences Receives Approval from The Nasdaq Stock Market LLC to Transfer the Listing of its Common Stock from the Nasdaq Global Select Market to the Nasdaq Capital Market Oct 26 Price target decreased by 15% to US$2.60The stock currently has a share float of 51.43%. Precision Biosciences Inc stock is held by 114 institutions, with Great Point Partners LLC being the largest institutional investor. By Jun 29, 2023, it held 6.49% of the shares, which is about 7.47 million shares worth $3.93 million.Precision BioSciences, Inc. is an advanced gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing …November 7, 2023 at 4:54 AM · 3 min read. Revenues for Q3 2023 were $13.1 million, a significant increase from $7.4 million in Q3 2022. Net loss for the quarter was $8.1 million, or $ (0.07) per ...Precision BioSciences, Inc. (DTIL) Stock Price, Quote, News & Analysis DTIL Precision BioSciences, Inc. Stock Price & Overview $0.37 0.0099 ( +2.79%) 3:59 …

DURHAM, N.C.--(BUSINESS WIRE)--Jun. 21, 2022-- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that it has agreed to sell 35,971,224 shares of its common stock at a price of …After the upgrade, the consensus from Precision BioSciences' five analysts is for revenues of US$37m in 2023, which would reflect a chunky 20% decline in sales compared to the last year of ...

Aug 1, 2023 · Stifel Nicolaus analyst Benjamin Burnett maintained a Buy rating on Precision BioSciences (DTIL – Research Report) yesterday and set a price target of $1.40.The company’s shares closed ... Precision BioSciences, Inc. Common Stock (DTIL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Precision Biosciences (NASDAQ:DTIL) is a biotech company with a proprietary gene-editing platform ... then I would expect the stock price to be below current price and no higher than $10, due to ...In June 2022, Precision announced the closing of an underwritten offering of 35,971,224 shares of its common stock at an offering price of $1.39 per share, ... Precision Biosciences, Inc. Condensed Consolidated Statements of Operations (In thousands, except share and per share amounts)DTIL's stock price has decreased by -71.36% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 3 stock analysts, the average 12-month stock price forecast for DTIL stock stock is $3.00, which predicts an increase of 607.88%.Precision BioSciences stock soars premarket on R&D collaboration and license pact with Novartis SA News Wed, Jun. 22, 2022 4 Comments. Precision BioSciences to sell ~36M shares for gross proceeds ...When it comes to precision cutting, having the right tool can make all the difference. That’s where the Super Cutter comes in. This innovative tool is designed to provide unparalleled accuracy and precision, making it a must-have for any DI...Source Headline; Precision BioSciences, Inc. (DTIL) finance.yahoo.com - November 30 at 1:02 PM Precision BioSciences to Present at Hep-DART 2023 finance.yahoo.com - November 30 at 8:02 AM: Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com - …Find the latest Precision BioSciences, Inc. (DTIL) stock quote, history, news and other vital information to help you with your stock trading and investing.Earnings Summary. For their last quarter, Precision BioSciences (DTIL) reported earnings of -$0.10 per share, beating the Zacks Consensus Estimate of $-0.19 per share. This reflects a positive ...

Alberta Precision Labs (APL) is a medical laboratory that offers a wide range of diagnostic tests and services. If you need to book an appointment with APL, there are a few things you should know before you go.

The latest price target for Precision BioSciences ( NASDAQ: DTIL) was reported by HC Wainwright & Co. on Tuesday, September 19, 2023. The analyst firm set a price target for 3.00 expecting DTIL to ...

Source Headline; Precision BioSciences, Inc. (DTIL) finance.yahoo.com - November 30 at 1:02 PM Precision BioSciences to Present at Hep-DART 2023 finance.yahoo.com - November 30 at 8:02 AM: Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com - …Discover historical prices for DTIL stock on Yahoo Finance. View daily, weekly or monthly format back to when Precision BioSciences, Inc. stock was issued.JonesTrading analyst Soumit Roy maintained a Buy rating on Precision BioSciences (DTIL – Research Report) today and set a price target of $4.00.The company’s shares opened today at $0.57. Roy ...Precision BioSciences presents Q4 figures on March 15. Analysts are expecting losses per share of $0.473. Watch Precision BioSciences stock price move in real-time ahead here.Precision BioSciences (NASDAQ: DTIL ), a biotechnology firm focusing on gene editing, announced that on November 21, the company's Compensation Committee authorized an inducement stock option for ...Jun 21, 2022 · Precision BioSciences Announces $50 Million Offering of Common Stock. June 21, 2022 05:25 PM Eastern Daylight Time. DURHAM, N.C.-- ( BUSINESS WIRE )--Precision BioSciences, Inc. (Nasdaq: DTIL), a ... Precision BioSciences Reports Third Quarter 2023 Financial Results and Provides Business Update. November 7, 2023 at 7:00 AM EST. PDF Version ... Weighted average shares of common stock outstanding-basic and diluted 115,174,752 110,849,196 Precision Biosciences, Inc. Condensed Balance Sheets Data ...Precision BioSciences Inc. 0.3787. Delayed Data. As of Nov 10. -0.0153 / -3.88%. Today’s Change. 0.28. Today ||| 52-Week Range.Stock Information · Financial Information · Investor Resources ... Erasca is a clinical-stage precision oncology company driven by a bold mission—to erase cancer.Detailed annual and quarterly income statement for Precision BioSciences, Inc. (DTIL). See many years of revenue, expenses and profits or losses. ... Stock Analysis Pro. Watchlist. Collapse. Precision BioSciences, Inc. (DTIL) NASDAQ: DTIL · IEX Real-Time Price · USD. Add to Watchlist 0.384

DTIL Stock Analysis: Potential +608.72% Increase According to Analysts Forecasts. DTIL stock, the ticker symbol for Precision BioSciences Inc, closed at a price of 0.42 on September 19, 2023. The 5 analysts offering 12-month price forecasts for DTIL have a median target of 3.00, with a high estimate of 4.00 and a low estimate of 1.40.When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.Stock analysis for Precision BioSciences Inc (DTIL:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Instagram:https://instagram. share price of glaxo smithklinequarters that worth moneyperrigo shareshow do i invest in water Precision BioSciences (NASDAQ: DTIL ), a biotechnology firm focusing on gene editing, announced that on November 21, the company's Compensation Committee authorized an inducement stock option for ... tesla earninagg ytd View the latest Precision Biosciences Inc. (DTIL) stock price, news, historical charts, analyst ratings and financial information from WSJ.DTIL's stock price has decreased by -71.36% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 3 stock analysts, the average 12-month stock price forecast for DTIL stock stock is $3.00, which predicts an increase of 607.88%. sphere las vegas inside Currently, the analyst consensus on Precision BioSciences is a Moderate Buy with an average price target of $10.50. See today’s best-performing stocks on TipRanks >> The company has a one-year ...Precision Biosciences Stock Earnings. The value each DTIL share was expected to gain vs. the value that each DTIL share actually gained. Precision Biosciences ( DTIL) reported Q3 2023 earnings per share (EPS) of -$0.14, beating estimates of -$0.18 by 21.37%. In the same quarter last year, Precision Biosciences 's earnings per share (EPS) was ...DURHAM, N.C.--(BUSINESS WIRE)--Jun. 8, 2022-- Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced its latest program updates across its allogeneic CAR T pipeline. The Company provided new clinical data and outlined ...